Legend Biotech (LEGN) Short-term Investments (2020 - 2025)

Legend Biotech has reported Short-term Investments for 6 years, with the latest figure at $70000.0 in Q2 2025.

• For the quarter ending Q2 2025, Short-term Investments fell 99.83% year-over-year to $70000.0; the trailing twelve-month figure through Jun 2025 stood at $70000.0 (down 99.83% YoY), and the FY2024 full-year result was $70000.0, down 89.44% from the prior year.
• Short-term Investments for Q2 2025 stood at $70000.0, roughly flat from $70000.0 in the prior quarter.
• The five-year high for Short-term Investments was $185.8 million in Q3 2023, with the low at $70000.0 in Q4 2024.
• Historically, Short-term Investments has averaged $83.7 million across 5 years, with a median of $50.0 million in 2021.
• Annual changes were most pronounced in 2021 — Short-term Investments surged 4258623.4% — and 2025, when it tumbled 99.95%.
• Legend Biotech's Short-term Investments stood at $1.4 million in 2021, then jumped by 12753.39% to $185.6 million in 2022, then tumbled by 99.64% to $663000.0 in 2023, then slumped by 89.44% to $70000.0 in 2024, then changed by 0.0% to $70000.0 in 2025.
• The last three Short-term Investments figures came in at $70000.0 (Q2 2025), $70000.0 (Q1 2025), and $70000.0 (Q4 2024), per Business Quant data.